This inventor holds 2 USPTO granted patents. Top assignee: Cho Pharma Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Ju-Mei Li: Innovator in Antibody Research
Introduction
Ju-Mei Li is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of antibody research, holding a total of 2 patents. His work focuses on innovative methods for cell enrichment and immune response induction.
Latest Patents
Ju-Mei Li's latest patents include a modified antibody designed for the enrichment of cells. This invention specifically binds to SSEA4, utilizing a glycol-engineered N-glycan. Additionally, he has developed an immune composition that comprises a glycoengineered antibody targeting the receptor binding domain (RBD) of a virus's surface protein. This composition aims to induce an immune response and offers a method for treating viral infections.
Career Highlights
Ju-Mei Li is currently associated with Cho Pharma Inc., where he continues to advance his research in antibody technology. His innovative approaches have the potential to impact therapeutic strategies significantly.
Collaborations
Some of his notable coworkers include Chien-Yu Chen and Chung-Yi Wu, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Ju-Mei Li's work exemplifies the spirit of innovation in the field of biotechnology. His patents reflect a commitment to enhancing medical treatments through advanced antibody research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile